SCHEMBL2452400

SCHEMBL2452400

CC1(C)c2ccccc2N(c2ccc(-c3ccccc3)cc2)c2ccc(-c3ccc(-n4c5ccccc5c5ccccc54)cc3)cc21

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 2/20 0.41
▸ KDM4E B2RXH2 1/20 0.41
▸ ATM Q13315 1/20 0.41
▸ HDAC4 P56524 1/20 0.40
▸ RXRA P19793 1/20 0.33
▸ RXRB P28702 1/20 0.33
▸ AKR1C4 P17516 1/20 0.32
▸ AKR1C3 P42330 1/20 0.32
▸ AKR1C2 P52895 1/20 0.32
▸ AKR1C1 Q04828 1/20 0.32
▸ ALDH1A1 P00352 2/20 0.31
▸ FAAH O00519 1/20 0.31
▸ MGLL Q99685 1/20 0.31
▸ TSPO P30536 1/20 0.31
▸ EGLN1 Q9GZT9 2/20 0.31
▸ KMT2A Q03164 2/20 0.31
▸ IL1R1 P14778 1/20 0.31
▸ EDNRA P25101 1/20 0.30
▸ PDE6D O43924 1/20 0.30
▸ MEN1 O00255 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20232361 0.99 HDAC4 (0.40) L3MBTL1KDM4EATMHDAC4RXRA
SCHEMBL14296737 0.98 L3MBTL1 (0.44) L3MBTL1KDM4EATMHDAC4RXRA
SCHEMBL13557602 0.96 HDAC4 (0.38) L3MBTL1KDM4EATMHDAC4RXRA
SCHEMBL13557749 0.96 L3MBTL1 (0.45) L3MBTL1KDM4EATMHDAC4RXRA
SCHEMBL2455750 0.95 L3MBTL1 (0.40) L3MBTL1KDM4EATMHDAC4RXRA
SCHEMBL13557747 0.94 KDM4E (0.41) L3MBTL1KDM4EATMHDAC4RXRA
SCHEMBL13557752 0.94 KDM4E (0.41) L3MBTL1KDM4EATMHDAC4RXRA
SCHEMBL13557757 0.94 KDM4E (0.41) L3MBTL1KDM4EATMHDAC4RXRA
SCHEMBL10309962 0.94 KDM4E (0.41) L3MBTL1KDM4EATMHDAC4RXRA
SCHEMBL13557758 0.93 KDM4E (0.42) L3MBTL1KDM4EATMHDAC4ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11264575-B2 Compounds for electronic devices MERCK PATENT GMBH (DE) 2022-03-01 — — US disclosed
US-10008673-B2 Compounds for electronic devices MERCK PATENT GMBH (DE) 2018-06-26 — — US disclosed
US-10008673-B2 Compounds for electronic devices MERCK PATENT GMBH (DE) 2018-06-26 — — US disclosed
US-20170155062-A1 COMPOUNDS FOR ELECTRONIC DEVICES MERCK PATENT GMBH (DE) 2017-06-01 — — US disclosed
US-20170155062-A1 COMPOUNDS FOR ELECTRONIC DEVICES MERCK PATENT GMBH (DE) 2017-06-01 — — US disclosed
US-20170155062-A1 COMPOUNDS FOR ELECTRONIC DEVICES MERCK PATENT GMBH (DE) 2017-06-01 — — US disclosed
US-9434877-B2 Organic electroluminescent device MERCK PATENT GMBH (DE) 2016-09-06 — — US disclosed
US-9434877-B2 Organic electroluminescent device MERCK PATENT GMBH (DE) 2016-09-06 — — US disclosed
US-20150060803-A1 COMPOUND HAVING ACRIDAN RING STRUCTURE, AND ORGANIC ELECTROLUMINESCENT DEVICE HODOGAYA CHEMICAL CO., LTD. (JP) 2015-03-05 — — US disclosed
US-20120326141-A1 ORGANIC ELECTROLUMINESCENT DEVICE MERCK PATENT GMBH (DE) 2012-12-27 — — US disclosed
US-20120326141-A1 ORGANIC ELECTROLUMINESCENT DEVICE MERCK PATENT GMBH (DE) 2012-12-27 — — US disclosed
US-20120319052-A1 COMPOUNDS FOR ELECTRONIC DEVICES MERCK PATENT GMBH (DE) 2012-12-20 — — US disclosed
US-20120319052-A1 COMPOUNDS FOR ELECTRONIC DEVICES MERCK PATENT GMBH (DE) 2012-12-20 — — US disclosed
US-20120319052-A1 COMPOUNDS FOR ELECTRONIC DEVICES MERCK PATENT GMBH (DE) 2012-12-20 — — US disclosed
WO-2011110262-A1 ORGANIC ELECTROLUMINESCENT DEVICE MERCK PATENT GMBH (DE) 2011-09-15 — — WO disclosed
WO-2011107186-A2 COMPOUNDS FOR ELECTRONIC DEVICES MERCK PATENT GMBH (DE) 2011-09-09 — — WO disclosed
WO-2011107186-A2 COMPOUNDS FOR ELECTRONIC DEVICES MERCK PATENT GMBH (DE) 2011-09-09 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11264575-B2 Compounds for electronic devices CYP2C19, CYP2C18, CYP1B1 L3MBTL1 4058/4885KDM4E 3090/4885ATM 4528/4885
US-20170155062-A1 COMPOUNDS FOR ELECTRONIC DEVICES CYP1B1, CYP1A1, CYP2E1 L3MBTL1 3745/4885KDM4E 2681/4885ATM 4337/4885
US-10008673-B2 Compounds for electronic devices CYP1B1, CYP1A1, CYP2E1 L3MBTL1 3745/4885KDM4E 2681/4885ATM 4337/4885
US-20120319052-A1 COMPOUNDS FOR ELECTRONIC DEVICES CYP1B1, CYP1A1, CYP2E1 L3MBTL1 3745/4885KDM4E 2681/4885ATM 4337/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback